ClinConnect ClinConnect Logo
Search / Trial NCT00428727

Clinical Trial for the Treatment of Diabetic Foot Ulcers Using a Nitric Oxide Releasing Patch: PATHON

Launched by FUNDACIÓN CARDIOVASCULAR DE COLOMBIA · Jan 26, 2007

Trial Information

Current as of May 29, 2025

Completed

Keywords

Diabetic Foot Ulcer Nitric Oxide Treatment Donor Controlled Trial

ClinConnect Summary

Background

Diabetes Mellitus (DM) constitutes one of the most important public health problems with a worldwide impact due to its high prevalence and enormous social and economic consequences. It is believed that there are more than 135 million diabetics, and this number is expected to increase to 300 million in the next 25 years (30% in developed and 70% in developing countries) \[1;2\].

This epidemic is related to several factors like ethnicity, the longer life expectancy, and the epidemiological and nutritional transition in developing countries due to the urbanization process that bri...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Men and women 18 years or older.
  • Capacity of attending the visits at the research site.
  • Confirmed diagnosis of DM type 1 or 2 according to the guidelines from the American Diabetes Association (ADA).
  • Presence of 1 or more DFU, less than 15cm in its biggest diameter, with a Texas University score ≤2.
  • Pharmacological treatment for glycemic control.
  • Willingness to participate in the study and to sign the informed consent form.
  • Exclusion Criteria:
  • Unconfirmed DM diagnosis.
  • Any pathology that, based on the judgment of the researcher, could alter the course of DFU (neoplasias, immunological disorders, etc).
  • Renal insufficiency requiring dialysis treatment.
  • DFU with a Texas score \>2.
  • Infected DFU with clinical or paraclinical findings suggesting osteomyelitis.
  • Critical ischemia of IL diagnosed by Doppler ultrasound and defined by ankle/arm index \< 0.5.
  • Clinical findings suggesting complicated venous insufficiency of IL.
  • Distal necrosis of the limb with the ulcer.
  • Pregnant or breastfeeding women.
  • Mentally or neurologically disabled patients that are considered not fit to approve their participation in the study.
  • Refusal to give informed consent.

About Fundación Cardiovascular De Colombia

Fundación Cardiovascular de Colombia is a leading research institution dedicated to advancing cardiovascular health through innovative clinical trials and comprehensive patient care. Established with a commitment to improving cardiovascular outcomes, the foundation engages in cutting-edge research that fosters collaboration among healthcare professionals, researchers, and patients. By prioritizing scientific excellence and ethical standards, Fundación Cardiovascular de Colombia aims to contribute significantly to the global understanding of cardiovascular diseases, ultimately enhancing treatment options and patient quality of life.

Locations

Bucaramanga, Santander, Colombia

Patients applied

0 patients applied

Trial Officials

Patricio López-Jaramillo, MD, PhD

Principal Investigator

Fundacion Cardiovascular de Colombia

Daniel J Smith, PhD

Principal Investigator

The University of Akron

Sandra Y Silva, MD

Study Chair

Fundacion Cardiovascular de Colombia

Ligia C Rueda, MD

Study Chair

Fundacion Cardiovascular de Colombia

Gustavo A Márquez, MD

Study Chair

Fundacion Cardiovascular de Colombia

Marcos López, PhD

Study Chair

The University of Akron

Piyaporn Kampeerapappun

Study Chair

The University of Akron

Juan C Castillo, MD

Study Chair

Fundacion Cardiovascular de Colombia

Carlos A Calderon, PhD

Study Chair

Fundación Santandereana de Diabetes y Obesidad

Jaime Matute, MD

Study Chair

Instituto de Seguros Sociales

Christian F Rueda-Clausen, MD

Study Chair

Fundacion Cardiovascular de Colombia

Arturo Orduz, MD

Study Chair

Fundacion Cardiovascular de Colombia

Federico A Silva, MD

Study Chair

Fundacion Cardiovascular de Colombia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials